Iron

SIGMA LITHIUM ANNOUNCES FINAL INVESTMENT DECISION AND INITIATION OF CONSTRUCTION TO DOUBLE PRODUCTION CAPACITY TO 520,000t/y

Retrieved on: 
Monday, April 1, 2024
Lithium, Letter, Growth, FCF, Sigma, Project, EVS, FID, Public expenditure, Carbon, ICE, Factory, Engineering, Parity, BNDES, Technical report, USD, Hand, Iron

SÃO PAULO , April 1, 2024 /PRNewswire/ -- SIGMA Lithium Corporation ("Sigma Lithium" or the "Company") (NASDAQ: SGML, TSXV: SGML, BVMF: S2GM34), a leading global lithium producer dedicated to powering the next generation of electric vehicles with carbon neutral, responsibly sourced lithium concentrate, today announced the Company's Board of Directors has made a Final Investment Decision ("FID") to double production of its unique Quintuple Zero Green Lithium from current 270,000t/y to 520,000t/y. The Board of Directors approved the initiation of construction of a second line of its Greentech Industrial Plant ("Phase 2 Industrial Greentech Plant") with Capex of $100mm (FEL3).

Key Points: 
  • Sigma Lithium announces that it concluded the Final Investment Decision to double production of its unique Quintuple Zero Green Lithium from current 270,000t/y to 520,000t/y.
  • Sigma Lithium was transformed from a construction site into the world's 6th largest global integrated producer of lithium concentrate.
  • Sigma Lithium became the world's 4th largest lithium industrial complex after approximately 60,000m 2023 campaign.
  • Sigma Lithium is also releasing its unaudited financial information for the fourth quarter and full year ended December 31, 2023.

Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2023

Retrieved on: 
Sunday, March 31, 2024
Shekel, Season, Tax, Agreement, Dorad Power Station, SWAP, Sale, P-50, Depreciation, Disclosure, Bank statement, RDL, Electricity, Klahim, Legislation, AMPA, Iron, Public expenditure, Good, Israeli new shekel, PPA, Zorlu, Komemiyut, Bank Mizrahi-Tefahot, Acquisition, PV, EBIDTA, Loss, D&O, Greenhouse, Government, Total, Renewable energy

•  Operating expenses were approximately €22.9 million for the year ended December 31, 2023, compared to approximately €23.7 million for the year ended December 31, 2022.

Key Points: 
  • •  Operating expenses were approximately €22.9 million for the year ended December 31, 2023, compared to approximately €23.7 million for the year ended December 31, 2022.
  • •  Project development costs were approximately €4.5 million for the year ended December 31, 2023, compared to approximately €3.8 million for the year ended December 31, 2022.
  • During 2023, the Ellomay Solar project (28 MW) produced revenues from the sale of electricity and green certificates of approximately €4 million.
  • The Company's EBITDA may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results.

Journal of Pharmaceutical Analysis (JPA) Studies Find Promising Drug Candidates

Retrieved on: 
Friday, March 29, 2024
Hydralazine, Issue 1, DHT, Pigment, UBA52, Neuroregeneration, Prevalence, Apoptosis, PNI, Serum, Homeostasis, Patient, Ferroptosis, JPA, Neuron, HYD, Metformin, Type, Nerve, BPH, Hypopigmentation, EB, Depigmentation, Met, Oxidative stress, Iron, Pharmaceutical industry

XI'AN, China, March 29, 2024 /PRNewswire/ -- Understanding the underlying mechanisms of normal and pathological cellular processes is essential for developing new drugs. Fortunately, modern techniques and experimental methods have greatly accelerated progress. The latest issue of JPA features three articles in which candidate compounds for treating complex disorders were successfully identified, alongside their detailed mechanisms of action.

Key Points: 
  • The first study investigated the use of metformin (Met), a drug used to manage type II diabetes, for treating benign prostate hyperplasia (BPH).
  • The article was published in Volume 14, Issue 1 of the journal in January 2024 .
  • Using the Drug Signatures Database, they identified hydralazine (HYD), a potent arterial vasodilator, as a potential UBA52 disruptor.
  • Further studies will hopefully clarify the intricate connections among cellular processes, diseases, and potential drugs, paving the way for precise and efficient therapies.

Global Oxygen Scavenger Market Forecasted to Grow $3.1 Billion by 2028: BCC Research

Retrieved on: 
Friday, March 29, 2024
DEHA, Longevity, Growth, Food packaging, Zinc, Cellulose, Paper, Metallic, Food, Mineral, Corrosion, Foodservice, Water quality, Oxygen, Safety, Power, Food safety, Key market, Iron, Landfill

BOSTON, March 29, 2024 /PRNewswire/ -- Oxygen scavengers preserve food and beverage products in packaging, prevent corrosion in boilers, and help reduce the staggering $400 billion annual global food waste. Government initiatives for sustainable packaging are boosting demand, making the oxygen scavenger market ripe for strategic advancements and investments.

Key Points: 
  • The form segmentation categorizes oxygen scavengers into powder, resin, and liquid forms, each tailored to specific application needs.
  • This report on the Global Oxygen Scavenger Market provides comprehensive insights and analysis, addressing the following key questions:
    1.
  • The global oxygen scavenger market is projected to grow from $2.3 billion in 2022 to $3.1 billion in 2028 at a compound annual growth rate (CAGR) of 5.1% during the forecast period.
  • These are the driving factors of the European oxygen scavenger market.

From Ningbo to the world: China's port city evolving into global opening-up hub

Retrieved on: 
Thursday, March 28, 2024
Belt, Tang dynasty, Culture, Growth, CEEC, Silk Road, Information, Travel, Maritime Silk Road, City, Double Eleven, Ship, Probability, Iron, Harbor

The high probability of this trade link comes from Ningbo's unique port status, according to Information Office of Municipal Government of Ningbo.

Key Points: 
  • The high probability of this trade link comes from Ningbo's unique port status, according to Information Office of Municipal Government of Ningbo.
  • It has become an important port and shipping logistics center, strategic resource allocation hub and modern shipping service base in the world.
  • Looking ahead, Ningbo aims to build an international opening-up hub city.
  • From a port city to an international hub for trade, Ningbo is set to make its mark on the global map.

From Ningbo to the world: China's port city evolving into global opening-up hub

Retrieved on: 
Thursday, March 28, 2024
Belt, Tang dynasty, Culture, Growth, CEEC, Silk Road, Information, Travel, Maritime Silk Road, City, Double Eleven, Ship, Probability, Iron, Harbor

The high probability of this trade link comes from Ningbo's unique port status, according to Information Office of Municipal Government of Ningbo.

Key Points: 
  • The high probability of this trade link comes from Ningbo's unique port status, according to Information Office of Municipal Government of Ningbo.
  • It has become an important port and shipping logistics center, strategic resource allocation hub and modern shipping service base in the world.
  • Looking ahead, Ningbo aims to build an international opening-up hub city.
  • From a port city to an international hub for trade, Ningbo is set to make its mark on the global map.

FERROFECT® Helps Address Anemia

Retrieved on: 
Wednesday, March 27, 2024
Pregnancy, Health, Absorption, Adenosine triphosphate, DNA replication, Cell, Zinc, DNA, Copper, Pharmacist, Quality of life, Woman, Supplement, Oxygen, ATP, WHO, Anemia, Iron, Digestion, Dietary supplement

FORT LAUDERDALE, Fla., March 27, 2024 /PRNewswire/ -- The body uses iron for many functions. Most of this iron is obtained through an individual's diet. However, when there is a chronic shortage of iron or the body struggles to synthesize it, it can be a problem. This can lead to iron deficiencies and anemia (the under-production of red blood cells, often due to a lack of iron). Three million Americans suffer from anemia, and WHO estimates that the condition globally impacts half a billion women and over a quarter of a billion children under the age of five.

Key Points: 
  • This can lead to iron deficiencies and anemia (the under-production of red blood cells, often due to a lack of iron).
  • Three million Americans suffer from anemia, and WHO estimates that the condition globally impacts half a billion women and over a quarter of a billion children under the age of five.
  • In addition, FERROFECT® helps with the production of adenosine triphosphate (ATP).
  • FERROFECT® even helps with DNA replication , a critical function required for cells to split and grow.

New Dataset Forges Fresh Path to Analyze Commodity Market Trends

Retrieved on: 
Tuesday, March 26, 2024
Data, Ursa, Iron, Iron ore

This subscription delivers unbiased and accurate data extracted from satellite imagery, empowering users to gain valuable insights in a notoriously opaque market and better understand economic trends.

Key Points: 
  • This subscription delivers unbiased and accurate data extracted from satellite imagery, empowering users to gain valuable insights in a notoriously opaque market and better understand economic trends.
  • This dataset offers a comprehensive picture of the iron ore market, akin to the role played by Ursa's Global Oil Inventories product.
  • Given the interconnected nature of iron ore with various commodities, currencies, and equities, this dataset is versatile across multiple asset classes.
  • The dataset includes portside stockpiles at five strategic locations considered pivotal in global iron ore trade:

Weston A. Price Foundation Proposes Deeper Look Into the Cause of TB

Retrieved on: 
Friday, March 22, 2024
Chelation, Crimean War, Industrial Age, Periodic breathing, Health, Meat, Siderosis, Cough, Natural gas, TIME, Lactoferrin, Coal, Mycobacterium tuberculosis, Disease, Tuberculosis, Incidence, Anglo-French Wars, Iron, Research, Mystery, Weston A. Price Foundation, Stainless steel, Death, Human, Bacillus, IRON, Atmosphere, Vaccination, Industrialisation, Contagious disease, TB, Power, Aluminium, Multimedia, Blood

DALLAS, March 22, 2024 /PRNewswire/ -- World TB Day, March 24, commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus believed to cause tuberculosis (TB). Koch argued that TB is a contagious disease, spreading from one person to the next through the air. Based on the notion that TB is caused by a contagious bacterium, conventional treatment for TB involves vaccination and administration of multiple antibiotics over a long period. New information requires the scientific community to reexamine the reigning theories about tuberculosis.

Key Points: 
  • DALLAS, March 22, 2024 /PRNewswire/ -- World TB Day, March 24, commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis , the bacillus believed to cause tuberculosis (TB).
  • Koch argued that TB is a contagious disease, spreading from one person to the next through the air.
  • "We propose looking elsewhere for the cause of TB," says Sally Fallon Morel of the Weston A.
  • "We propose looking elsewhere for the cause of this terrible illness," says Sally Fallon Morell, president of the Weston A.

Celebrity Homes: The Judy Garland House - She Bought It the Same Year She Was Signed To Star in 'The Wizard of Oz'

Retrieved on: 
Wednesday, March 20, 2024
Art Deco, Friends, Real estate, Relaxation, A Star Is Born, The Wizard of Oz, Sale, Wizard, Judgment at Nuremberg, Grammy Awards, Easter parade, Architectural Digest, System, Judy Garland, Academy Awards, Tree, MGM, Fredric March, Iron, Interior design

POMPANO BEACH, Fla., March 20, 2024 /PRNewswire-PRWeb/ --

Key Points: 
  • The Los Angeles home that Judy Garland bought in 1938 – the same year she turned age 16 and was signed to star in "The Wizard of Oz" – is for sale at $11.5 million.
  • One of LA's classic celebrity homes has come on the market.
  • The Bel-Air home that Judy Garland bought in 1938 – the same year she turned age 16 and was signed to star in "The Wizard of Oz" – is for sale at $11.5 million.
  • Later in her career, Judy received Academy Award nominations for her performances in "A Star Is Born" and "Judgement at Nuremberg."